A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2006
11/30/2006	CA2604165A1 Novel substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives and their use as a medicament
11/29/2006	EP1726952A1 Method of in vivo screening of therapeutic agent for memory/learning dysfunction by schizophrenia
11/29/2006	EP1726592A1 Dioxino derivatives and their use as dopanine agonists
11/29/2006	EP1726590A1 Cycloalkanopyridine derivative
11/29/2006	EP1726585A1 Diaryl-substituted five-membered heterocycle derivative
11/29/2006	EP1726584A1 2-aminoquinazoline derivative
11/29/2006	EP1726307A2 Methods for treating psychosis associated with glucocorticoid related dysfunction
11/29/2006	EP1726306A1 Fasudil-containing preparation and method of improving stability thereof
11/29/2006	EP1725543A1 4-benzimidazol-2-yl-pyridazine-3-one-derivatives, production and use thereof in medicaments
11/29/2006	EP1725537A1 Novel compounds as opioid receptor modulators
11/29/2006	EP1725518A1 Pharmaceutical compounds
11/29/2006	EP1725261A2 Use for interleukin-33 (il-33) and the il-33 receptor complex
11/29/2006	EP1725239A1 4-(sulfanyl-pyrimidin-4-ylmethyl)-morpholine derivatives and related compounds as gaba receptor ligands for the treatment of anxiety, depression and epilepsy
11/29/2006	EP1725238A2 M 3 muscarinic acetylcholine receptor antagonists
11/29/2006	EP1725226A2 The treatment of inflammatory disorders and pain using beta-aminoalcohols
11/29/2006	EP1725222A2 Methods and compositions for treating or preventing psychiatric disorders with cox-2 inhibitors alone and in combination with antidepressant agents
11/29/2006	EP1725101A1 2-pyridinyl [7-(substituted-pyridin-4-yl) pyrazolo[1,5-a] pyrimidin-3-yl] methanones
11/29/2006	EP1480624B1 Pharmaceutical tablet
11/29/2006	EP1401424B1 Carbamate compounds for use in preventing or treating psychotic disorders
11/29/2006	EP1259223A4 Protein matrix materials, devices and methods of making and using thereof
11/29/2006	EP1248804B1 Recombinant antibodies to human interleukin-1 beta
11/29/2006	EP1218403B1 Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery
11/29/2006	EP1117801B1 Polyketide synthase enzymes and recombinant dna constructs therefor, for the production of compounds related to fk-506 and fk-520
11/29/2006	EP1032559B1 Aminoalkylphenol derivatives for treating depression and memory dysfunction
11/29/2006	EP0738149B1 1-aminoindan derivatives and compositions thereof
11/29/2006	EP0605501B2 Use of presynaptic neurotoxin for the treatment of cerebral palsy
11/29/2006	CN1871243A Oral neurotherapeutic cefazolin compositions
11/29/2006	CN1871242A 3-(4-aminophenyl) thienopyrimid-4-one derivatives as MCH R1 antagonists for the treatment of obesity, diabetes, depression and anxiety
11/29/2006	CN1871241A Spirofuropyridine aryl derivatives
11/29/2006	CN1871240A Pyrrolopyrimidine thion derivatives
11/29/2006	CN1871238A Triaza-spiropiperidine derivatives for use as GLYT-1 inhibitors in the treatment of neurological and neuropsychiatric disorders
11/29/2006	CN1871235A Azabicyclic-substituted fused heteroaryl compounds for the treatment of disease
11/29/2006	CN1871234A 2-amino-4-heteroarylethyl thiazoline derivatives and their use as inhibitors of inducible no-synthase
11/29/2006	CN1871226A Dihydrobenzofuranyl alkanamines and pharmaceutical compositions containing them
11/29/2006	CN1871224A 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
11/29/2006	CN1871030A Method of inhibiting secretase activity
11/29/2006	CN1871029A Drug containing chymase inhibitor as the active ingredient
11/29/2006	CN1871013A Benzazepine derivatives as MAO-B inhibitors
11/29/2006	CN1871004A The use of ifenprodril in the treatment of pain
11/29/2006	CN1871000A Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pain
11/29/2006	CN1870993A Pharmaceutical compositions based on idazoxan salt or one of the polymorphs thereof
11/29/2006	CN1870980A Controlled release sterile injectable aripiprazole formulation and method
11/29/2006	CN1869204A Use of icariin in inducting dry cell body in-vitro directional differentiation
11/29/2006	CN1869051A Preparation method of trialcohol group ginseng saponine and dialcohol group ginseng saponine
11/29/2006	CN1868999A Preparation method of 3-fluoro-5-nitro trifluor toluene
11/29/2006	CN1868540A Mixture prepn. and its application
11/29/2006	CN1868539A Mixture prepn. and its application
11/29/2006	CN1868526A Soft capsule of active rhizoma gastrodiae, and its prepn. method
11/29/2006	CN1868500A Medicine composition contg. tetramethylpyrazine, prepn. method and use thereof
11/29/2006	CN1868487A Use of stub-like bacillus prepn. or acellular stub-like bacillus prepn.
11/29/2006	CN1868480A Methods for inhibiting cognitive deterioration in adults with down's syndrome
11/29/2006	CN1868472A Tablets of Lizakuputan benzoate
11/29/2006	CN1868467A Aceglutamine prepn. for injection, and its preparing method
11/29/2006	CN1868458A Controlled release composition and method of producing the same
11/29/2006	CN1286835C Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
11/29/2006	CN1286834C Benzothiazoles compound
11/29/2006	CN1286833C Indole and 2,3-indoline derivative, their preparation and application
11/29/2006	CN1286822C Pyrimidinone compounds
11/29/2006	CN1286815C Novel 4-anilinoquinoline-3-carboxamides compound
11/29/2006	CN1286524C Use of OPN for treatment and/or prevention of neurological diseases
11/29/2006	CN1286508C Compound health tea
11/29/2006	CN1286451C Pharmaceutical formulation for efficient administration of apomorphine, 6aR-(-)-N-propyl-norepomorphine and their derivatives and pro-drugs thereof
11/28/2006	US7141656 In situ screening, isolation of peptides; major histocompability complex
11/28/2006	US7141606 Muscle relaxation; brain disorders; antiepileptic agents
11/28/2006	US7141580 activity as prostaglandin E2 receptor antagonists
11/28/2006	US7141575 Triazolo[4,5-d]pyrimidine derivatives and their use as purinergic receptor antagonists
11/28/2006	US7141573 Huntington's diseases, Alzheimer's diseases, psychological disorders
11/28/2006	US7141572 For therapy of osteoporosis, tumours, cachexia, atherosclerosis, rheumatoid arthritis, multiple sclerosis, diabetes mellitus, inflammatory processes, allergies, asthma, autoimmune diseases, myocardial diseases and AIDS
11/28/2006	US7141569 Antiviral pyrazolopyridine compounds
11/28/2006	US7141566 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments
11/28/2006	US7141563 Used for prophylaxis and therapy of central nervous system disorders, including obsessive-compulsive disorder, depression, anxiety, generalized anxiety disorder, schizophrenia, panic disorder, migraine, sleep disorders
11/28/2006	US7141562 Central nervous system disorders; Parkinson's disease; Huntington's diseases; antidepressants; anxiolytic agents
11/28/2006	US7141560 For use as analgesic or sedative; treating sleep disorders
11/28/2006	US7141558 2-ethyl and 2-ethylidene-19-nor-vitamin D compounds
11/28/2006	US7141555 Water solubility, bioavailability, oral administration; unit dosage
11/28/2006	US7141383 EDG8 receptor, its preparation and use
11/28/2006	US7141363 Purposeful movement of human migratory cells away from an agent source
11/28/2006	US7141247 Intravenous valproate for acute treatment of migraine headache
11/28/2006	CA2379786C Purine derivatives
11/28/2006	CA2379640C Certain alkylene diamine-substituted heterocycles
11/28/2006	CA2375524C 3-(arylsulfonylamino)-tetrahydropyran-3-carboxylic acid hydroxamides
11/28/2006	CA2375513C 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides
11/28/2006	CA2275379C Use of pramipexole in the treatment of restless legs syndrome
11/28/2006	CA2173582C Nitric esters having anti-inflammatory and/or analgesic activity and process for their preparation
11/28/2006	CA2160444C Aroyl-piperdine derivatives
11/28/2006	CA2150945C Ibuprofen-containing effervescent pharmaceutical composition and process for preparing the same
11/28/2006	CA2137203C Protein kinase c inhibitors
11/23/2006	WO2006124862A2 Methods for the treatment of ocular and neurodegenerative conditions in a mammal
11/23/2006	WO2006124753A2 Antipyretic agents against vr1-antagonist-induced increases in body temperature
11/23/2006	WO2006123827A1 Method for amelioration of disease condition induced by mood disorder
11/23/2006	WO2006123724A1 Novel pharmaceutical using anti-hla antibody
11/23/2006	WO2006123678A1 Stable tablet containing droxidopa
11/23/2006	WO2006123675A1 Protective agent for neurocyte comprising amidino derivative as active ingredient
11/23/2006	WO2006123644A1 Int6 PROTEIN INVOLVED IN HYPOXIA STRESS INDUCTION AND USE THEREOF
11/23/2006	WO2006123639A1 Pyrimidine derivative
11/23/2006	WO2006123466A1 Drugs, food or drink for improving pancreatic functions
11/23/2006	WO2006123364A2 Oral drug delivery system providing a coating comprising both a cellulose and a methacrylic acid derivative
11/23/2006	WO2006123244A2 Carbamate derivatives as positive allosteric modulators of metabotropic glutamate receptors
11/23/2006	WO2006122776A1 Substituted benzo-condensed cycloheptanone derivatives and their use for producing drugs
11/23/2006	WO2006122680A1 Use of a benzoyl derivative of 3-aminocarbazole for the treatment of a disorder associated with the production of prostaglandin e2 (pge2)

1 ... 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 ... 1833